Gilead beat quarterly profit and sales estimates and raised its sales forecast, but cut its full-year profit forecast. Analysts also raised price targets, yet the results point in different directions for the company.
The sales results and higher sales forecast suggest demand is holding up. Analysts also raised their price targets. But Gilead lowered its full-year profit range as it raised its sales range. That split leaves the outlook mixed.
Follow Gilead Sciences, Inc. (GILD) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GILD